Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6247351 | 0.81 | OXTR (0.53) | OXTRAVPR1A | |
| SCHEMBL13801271 | 0.80 | OXTR (0.46) | OXTRAVPR1A | |
| SCHEMBL7447387 | 0.78 | OPRL1 (0.69) | OXTRAVPR1A | |
| SCHEMBL5768740 | 0.77 | HTR2C (0.48) | OXTRAVPR1A | |
| SCHEMBL14410177 | 0.77 | OXTR (0.47) | OXTRAVPR1A | |
| SCHEMBL14486768 | 0.77 | OPRM1 (0.52) | OXTRAVPR1A | |
| SCHEMBL8863377 | 0.77 | OXTR (0.50) | OXTRAVPR1A | |
| SCHEMBL6247970 | 0.77 | OXTR (0.49) | OXTRAVPR1A | |
| SCHEMBL8863371 | 0.77 | OXTR (0.54) | OXTRAVPR1A | |
| SCHEMBL22605617 | 0.76 | OXTR (0.47) | OXTRAVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7498325-B2 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | KARL THOMAS GMBH (DE) | 2009-03-03 | — | — | US | disclosed |
| US-20040214819-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | DR. KARL THOMAE GMBH (DE) | 2004-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214819-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, SRMS, OPRM1 | OXTR 63/4885AVPR1A 105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.